The combined effect of si-ATF3 and miR-222 inhibitor on the proliferation of CRC cells was assessed by EdU, which revealed a significant augment in the proliferation of CRC cells after ATF3 downregulation (Fig. 5a). The gene discussed is ATF3; the disease is colorectal carcinoma.